Valeo Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Valeo Financial Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-834	Closed	-$46K	–	2301
2020 Q2	$46K	Hold	834	–	–	﹤0.01%	767
2020 Q1	$26K	Hold	834	–	–	﹤0.01%	822
2019 Q4	$30K	Buy	834 +157	+23%	+$4.81K	﹤0.01%	821
2019 Q3	$18K	Buy	677 +500	+282%	+$12.9K	﹤0.01%	883
2019 Q2	$4K	Sell	177 -147	-45%	-$3.73K	﹤0.01%	1308
2019 Q1	$9K	Buy	324 +177	+120%	+$4.19K	﹤0.01%	1011
2018 Q4	$3K	Hold	147	–	–	﹤0.01%	1245
2018 Q3	$3K	Buy	+147	New	+$2.79K	﹤0.01%	1408

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Valeo Financial Advisors's HZNP Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 834 shares — an estimated $46K sold.

Valeo Financial Advisors first reported a position in HZNP in Q3 2018 and held it in 8 quarters. The position peaked at $46K in Q2 2020. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

Valeo Financial Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Valeo Financial Advisors sold 834 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $46K.
Valeo Financial Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 8 quarters.
Valeo Financial Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $46K in Q2 2020.
433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.